Seagen to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
BOTHELL, Wash.--(BUSINESS WIRE)-- Seagen Inc. (Nasdaq:SGEN) today announced that management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022 at 12:55 p.m. Eastern Time. The presentation will be webcast live and available for replay from the investor section of Seagen’s website at investor.seagen.com.
About Seagen
Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220907005157/en/
Contacts
For Investors
Douglas Maffei, Ph.D.
(425) 527-4881
dmaffei@seagen.com
For Media
David Caouette
(310) 430-3476
dcaouette@seagen.com
Source: Seagen Inc.
View this news release online at:
http://www.businesswire.com/news/home/20220907005157/en